The trial investigating Mesenchymal Precursor Cell (MPC)-based expansion and ex-vivo fucosylation of hematopoietic stem cells (HSCs) for rapid cord blood engrafment for bone marrow transplant cancer patients .
Phase of Trial: Phase II
Latest Information Update: 03 Jan 2017
At a glance
- Drugs Rexlemestrocel-L (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 03 Jan 2017 New trial record